Reports

564 Results (Page 23 of 23)

Egypt Markets Research Reports

Pharmaceuticals

Egypt Clinical Nutrition Market Analysis

The Egypt Clinical Nutrition Market was valued at $85.9 Mn in 2023 and is projected to grow at a CAGR of 6.84% from 2023 to 2023, to $136.5 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Bio Pharma, Eva Pharma, Bio Pure, SEDICO, Abbott Nutrition, Mead Johnson & Company, LLC among others

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

Egypt Breast Pump Market Report

The Egypt Breast Pump Market was valued at $8.2 Mn in 2023 and is predicted to grow at a CAGR of 10.1% from 2023 to 2030, to $16.1 Mn by 2030. The key drivers of the market include improving healthcare infrastructure, growing consumer awareness, and rising disposable incomes. The prominent players in the Egypt Breast Pump Market are Bistos, Ameda, Avent, Evenflo, and Pigeon, among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Cancer Induced Bone Diseases Therapeutics Market

Egypt Cancer Induced Bone Disease Therapeutics Market valued at $4 Mn in 2022, projected to reach $6 Mn by 2030 with a 7.3% CAGR. The key drivers of this industry include the rising incidence of cancer, expanding treatment options, and improved diagnoses. The industry is primarily dominated by players such as EVA, AstraZeneca, Merck, Eli Lilly, Pharco, Johnson & Johnson, Amgen, and Novartis among others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Congestive Heart Failure Therapeutics Market Analysis

The Egypt Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $29 Mn in 2022 to $51 Mn by 2030, with a CAGR of 7.3% during the forecast period of 2022-2030. The primary drivers in Egypt are the increasing incidence of cardiovascular illnesses, increased consciousness, early detection made possible by technological developments in the field, and the revolutionary stage of CHF treatments with ongoing research and development. The Egypt Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Roche, Gilead Sciences, Copad Pharma, EVA Pharma, Pharco, Pharmaceuticals, Tabia Pharmaceuticals, etc, among various others.

PUBLISHED: Jun, 2024 | FORMAT: PPT | LAST UPDATED: Jun, 2024 | PRICE: $3999

Medical Devices

Egypt Biosensors Market Analysis

The Egypt Biosensors Market was valued at $80.9 Mn in 2023 and is predicted to grow at a CAGR of 9.5% from 2023 to 2030, to $152.7 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and growing demand for Point-of-Care (POC) testing. The prominent players of the Egypt Biosensors Market are BM-Egypt, Kimal, Medtronic, Abbot Laboratories, and Johnson & Johnson, among others

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Digital Health

Egypt Digital Biomarkers Market Analysis

Egypt Digital Biomarkers Market was valued at $8.12 Mn in 2023 and is predicted to grow at a CAGR of 23.8% from 2023 to 2030, to $36.19 Mn by 2030. The key drivers of this industry include the rising burden of chronic diseases, government initiatives, and a growing focus on preventative care. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Healthcare Services

Egypt Medication Access Programs Market Analysis

The Egypt Medication Access Programs Market was valued at $15.4 Mn in 2023 and is predicted to grow at a CAGR of 16.1% from 2023 to 2030, to $43.7 Mn by 2030. The key drivers of this industry include disease burden, government initiatives, and patient education and awareness. The industry is primarily dominated by players such as Takeda Pharmaceuticals, Pfizer, Novartis, and Merck among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Cardiac Resynchronization Therapy Market

Egypt Cardiac Resynchronization Therapy Market valued at $13 Mn in 2022, projected to reach $22 Mn by 2030 with a 6.5% CAGR. The significant rise in global heart failure instances, driven by aging populations and cardiovascular conditions linked to lifestyle, emerges as a crucial catalyst propelling the expansion of the Cardiac Resynchronization Therapy (CRT) market. Currently, major participants in this market include Abbott, Biotronik, Boston Scientific, Medtronic, St. Jude Medical, Sorin Group, Siemens Healthineers, Philips Healthcare, GE Healthcare, and Esaote.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Medical Devices

Egypt Physiotherapy Equipment Market Analysis

The Egypt Physiotherapy Equipment Market was valued at $58.52 Mn in 2023 and is predicted to grow at a CAGR of 8.7% from 2023 to 2030, to $104.93 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are AB Care Medical Technology, BTL Industries, AMECO Egypt, and Blue Shell Store among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Healthcare Services

Egypt Patient Adherence Programs Market Analysis

The Egypt Patient Adherence Programs Market was valued at $36.3 Mn in 2023 and is predicted to grow at a CAGR of 19.5% from 2023 to 2030, to $126.2 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players in the Egypt Patient Adherence Programs Market are Eva Pharma, Rameda Pharmaceuticals, MUP (Medical Union Pharmaceuticals), Sedico Pharmaceuticals, and EIPICO (Egyptian International Pharmaceutical Industries Co), among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Cardiac Arrhythmia Therapeutics Market

Egypt Cardiac Arrhythmia Therapeutics Market valued at $20 Mn in 2022, projected to reach $35 Mn by 2030 with a 7.3% CAGR. The key drivers of this industry include the increasing prevalence of cardiac arrhythmias, government initiatives, and technological advances. The industry is primarily dominated by players such as Abbott, Hikma, EPharm, Pharco, Sanofi, Boehringer Ingelheim, and AstraZeneca among others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Pharmaceuticals

Egypt LASIK Surgery Market Analysis

Egypt LASIK Surgery Market was valued at $9.88 Mn in 2023 and is predicted to grow at a CAGR of 6.71% from 2023 to 2030, to $15.57 Mn by 2030. The key drivers of this industry include the rising prevalence of vision problems, growing middle class and disposable income, and increasing awareness and marketing. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Digital Health

Egypt Medical Digital Imaging System Market Analysis

The Egypt Medical Digital Imaging System Market was valued at $85.4 Mn in 2023 and is predicted to grow at a CAGR of 9.7% from 2023 to 2030, to $163.27 Mn by 2030. The key drivers of this industry include a rising aging population, increasing healthcare investment, and supportive government initiatives. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

Egypt Breastfeeding Accessories Market Analysis

Egypt Breastfeeding Accessories Market was valued at $7.03 Mn in 2023 and is predicted to grow at a CAGR of 8.30% from 2023 to 2030, to $12.28 Mn by 2030. The key drivers of this industry include increasing awareness of breastfeeding benefits, a rising middle-class population, and improved healthcare infrastructure. The industry is primarily dominated by Medala, Elvie, Willow Innovations, and Koninklijke Philips among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

subscribe to our newsletter